Carbylan Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Carbylan Therapeutics, Inc.
CIK #0001348911
EDGAR Form CIK 2011 - 2025
10-K [0001348911]
10-Q [0001348911]
3 [0001348911]
4 [0001348911]
8-K [0001348911]
D [0001348911]
SC 13D [0001348911]
SC 13G [0001348911]
Form 13D/13G Filer Form 13D/13G Subject Filed
Vestal Point Capital LP KalVista Pharmaceuticals Inc [2024-11-14]
Capital World Investors KalVista Pharmaceuticals Inc [2024-11-13]
Adage Capital Partners GP LLC KalVista Pharmaceuticals Inc [2024-02-26]
Vanguard Group Inc KalVista Pharmaceuticals Inc [2024-02-13]
Saturn V Capital Management LP KalVista Pharmaceuticals Inc [2024-02-12]
BlackRock Inc KalVista Pharmaceuticals Inc [2024-01-29]
Suvretta Capital Management LLC KalVista Pharmaceuticals Inc [2023-03-10]
FMR LLC KalVista Pharmaceuticals Inc [2023-02-09]
TCG Crossover GP I LLC KalVista Pharmaceuticals Inc [2023-01-09]
Venrock Healthcare Capital Partners III LP KalVista Pharmaceuticals Inc [2023-01-09]
View All
Form 3/4/5 Subject 2011 - 2025
KalVista Pharmaceuticals, Inc.
Palleiko Benjamin L
Audhya Paul K.
Yea Christopher
Shah Nimish P
Koh Bong Y
Venrock Healthcare Capital Partners III, L.P.
VHCP Co-Investment Holdings III, LLC
VHCP Management III, LLC
VHCP Management EG, LLC
View All
Terms | Privacy | Guide
tony@aum13f.com